Dyne Therapeutics (DYN) Assets (2019 - 2026)
Dyne Therapeutics (DYN) posted quarterly Assets of $994.0 million for Q2 2026, up 36.35% year-over-year from $729.0 million in Q2 2025, and down 7.96% quarter-over-quarter from $1.1 billion in Q1 2026.
Dyne Therapeutics (DYN) Assets (2019 - 2026) Analysis & Trends
Dyne Therapeutics (DYN) has reported Assets for 8 consecutive years, with $994.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Assets rose 36.35% year-over-year to $994.0 million; the TTM figure through Jun 2026 stood at $994.0 million (up 36.35% YoY), while the FY2025 annual figure was $1.2 billion, up 71.72% from the prior year.
- Assets declined to $994.0 million in Q2 2026 per DYN's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Assets topped out at $1.2 billion in Q4 2025 and bottomed at $165.1 million in Q4 2023.
- Historically, Assets has averaged $590.6 million across 5 years, with a median of $606.8 million in 2024.
- Annual changes were most pronounced in 2023 — Assets tumbled 46.11% — and 2024, when it jumped 318.72%.
- Dyne Therapeutics' Assets stood at $306.3 million in 2022, then tumbled by 46.11% to $165.1 million in 2023, then surged by 318.72% to $691.2 million in 2024, then soared by 71.72% to $1.2 billion in 2025, then declined by 16.26% to $994.0 million in 2026.
- Business Quant data shows DYN's Assets at $994.0 million in Q2 2026, $1.1 billion in Q1 2026, and $1.2 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Dyne Therapeutics | 4.26 Bn | 4.26 Bn | - | 994.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 994.01 Mn |
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.19 Bn |
| Sep 30, 2025 | 867.06 Mn |
| Jun 30, 2025 | 728.99 Mn |
| Mar 31, 2025 | 721.07 Mn |
| Dec 31, 2024 | 691.23 Mn |
| Sep 30, 2024 | 768.84 Mn |
| Jun 30, 2024 | 825.88 Mn |
| Mar 31, 2024 | 522.28 Mn |
| Dec 31, 2023 | 165.08 Mn |
| Sep 30, 2023 | 205.24 Mn |
| Jun 30, 2023 | 251.42 Mn |
| Mar 31, 2023 | 288.64 Mn |
| Dec 31, 2022 | 306.33 Mn |
| Sep 30, 2022 | 299.68 Mn |
| Jun 30, 2022 | 340.03 Mn |
| Mar 31, 2022 | 387.76 Mn |
| Dec 31, 2021 | 425.66 Mn |
| Sep 30, 2021 | 466.88 Mn |